Adknoma Health Research   Report issue

For profit Phase 1 Phase 2
Founded: Madrid Spain (2004)

Organization Overview

First Clinical Trial
2012
NCT01529320
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Adknoma Health Research | Adknoma Health Research, S.L.